Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease.

Nichols KK, Donnenfeld ED, Karpecki PM, Hovanesian JA, Raychaudhuri A, Shojaei A, Zhang S.

DOI: 10.1177/1120672118791936
Published: 2018-08-16
Container: Eur J Ophthalmol
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/1120672118791936,
  title = {Safety and tolerability of lifitegrast ophthalmic solution 5.0\%: Pooled analysis of five randomized controlled trials in dry eye disease.},
  author = {Nichols KK and  Donnenfeld ED and  Karpecki PM and  Hovanesian JA and  Raychaudhuri A and  Shojaei A and  Zhang S.},
  year = {2019},
  journal = {Eur J Ophthalmol},
  doi = {10.1177/1120672118791936},
  url = {https://doi.org/10.1177/1120672118791936}
}

RIS

TY  - JOUR
TI  - Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease.
AU  - Nichols KK
AU  -  Donnenfeld ED
AU  -  Karpecki PM
AU  -  Hovanesian JA
AU  -  Raychaudhuri A
AU  -  Shojaei A
AU  -  Zhang S.
PY  - 2019
JO  - Eur J Ophthalmol
DO  - 10.1177/1120672118791936
UR  - https://doi.org/10.1177/1120672118791936
ER  -

APA

KK, N., ED, D., PM, K., JA, H., A, R., A, S., & S., Z. (2019). Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease.. Eur J Ophthalmol. https://doi.org/10.1177/1120672118791936

Source records

europe-pmc · retrieved 2026-09-27T02:56:44.102Z